Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. 投资者可以进行盘前(美国东部时间上午 4:00 - 9:30) 和盘后(美国东部时间下午 4:00 - 8:00) 交易。做市商和 ECN 严格自愿参与,因此,这些时段的流动性和价格会比较低。在这种环境下,股票价格也可能波动更快。
Get the latest updates on Zealand Pharma A/S. (ZLDPF) pre market trades, share volumes, and more. Make informed investments with Nasdaq.
Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome Copenhagen, Denmark, December22, 2023–Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no. 20045078), a biotechnology company focused on...
About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market ...
BI 456906用于治疗肥胖和非酒精性脂肪肝炎的II期临床试验是勃林格殷格翰与Zealand Pharma长期合作的一部分，此前BI 456906的II期临床试验用于治疗2型糖尿病已于2020年启动。德国殷格翰和丹麦哥本哈根2021年4月14日 /美通社/ -- 勃林格殷格翰和Zealand Pharma A/S公司（"Zealand"）（NASDAQ：ZEAL）宣布启动两项针对...
Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market...
INGELHEIM, Germany, & COPENHAGEN, Denmark--(BUSINESS WIRE)--Boehringer Ingelheim and Zealand Pharma A/S (Nasdaq: ZEAL) today announced that patients treated with BI 456906 achieved up to 14.9% weight loss after 46 weeks, using the planned maintenance dose. The phase II clinical trial evaluating...
Zealand Pharma A/S (ZEAL) Q4 2019 Earnings Call Transcript ZEAL earnings call for the period ending December 31, 2019. Motley Fool Transcribers | Mar 12, 2020 View More ZEAL Earnings Transcripts Related Stocks NASDAQ: GILD Gilead Sciences ...
Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reach...
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery, development, and commercialization of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the ...